X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
Clinical trial NCT03753685 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03753685
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-12
- Primary completion
- 2025-06-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.